Isao Kawaguchi

6PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRheumatology and arthritisClinical pharmacology and therapeuticsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 18, 2026
Health state utilities for relapsed or refractory large B-cell lymphoma treatments: a time trade-off study in the Japanese general population.

Shigeo Fuji, Hiroshi Ando, Kana Takaura

|Mar 21, 2024
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib.

Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa

|Nov 10, 2023
Healthcare resource utilisation and economic burden of patients with adequate and inadequate responses to biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis in Japan.

Kei Ikeda, Yuko Kaneko, Yuki Tsujita

|Feb 10, 2022
Number needed to treat and cost per responder of Janus kinase inhibitors approved for the treatment of moderate-to-severe rheumatoid arthritis in Japan.

Tatsuya Atsumi, Eri Asakura, Michio Doi

|Nov 24, 2021
Evaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomes.

Hiroyuki Murota, Yuta Koike, Kanako Ishii

|Dec 07, 2019
A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan.

Isao Kawaguchi, Kazuaki Chayama, Yuri Sanchez Gonzalez

Pageof 1

Frequent Collaborators

1 joint publications

Hiroyuki Murota

1 joint publications

Yuta Koike

1 joint publications

Kanako Ishii

1 joint publications

Brian M Calimlim